| First Author | Reynolds KE | Year | 2021 |
| Journal | J Neuroimmunol | Volume | 361 |
| Pages | 577745 | PubMed ID | 34695768 |
| Mgi Jnum | J:336667 | Mgi Id | MGI:7435484 |
| Doi | 10.1016/j.jneuroim.2021.577745 | Citation | Reynolds KE, et al. (2021) Converging purinergic and immune signaling pathways drive IL-6 secretion by Fragile X cortical astrocytes via STAT3. J Neuroimmunol 361:577745 |
| abstractText | The symptoms of Fragile X syndrome (FXS) are driven in part by abnormal glial-mediated function. FXS astrocytes release elevated levels of immune-related factors interleukin-6 (IL-6) and tenascin C (TNC), and also demonstrate increased purinergic signaling, a pathway linked to signaling factor release. Here, in cortical astrocytes from the Fmr1 knockout (KO) FXS mouse model, purinergic agonism enhanced TNC secretion and STAT3 phosphorylation, two processes linked to elevated IL-6 secretion in FXS, while STAT3 knockdown and TLR4 antagonism normalized Fmr1 KO IL-6 release. We therefore suggest that purinergic signaling and immune regulatory pathways converge to drive FXS cortical pro-inflammatory responses. |
